OBJECTIVES: Rutin, quercetin-3-O-rutinoside, a natural flavonol glycoside, has shown various in vitro benefits with potential use treating human diseases, especially cardiovascular system disorders. Antioxidant properties are assumed to underlie the majority of these benefits. Yet rutin pro-oxidant properties have been reported as well. Our research group has recently shown aggravating effects on isoprenaline (ISO)-induced cardiotoxicity in Wistar:Han rats after 24 hours. METHODS: This study was designed to examine in more detail the reasons for the negative effects of rutin (11.5 and 46 mg/kg, i.v.) after administration of ISO (100 mg/kg, s.c.) in rats within 2 hours of continuous experiment and in the H9c2 cardiomyoblast-derived cell line. RESULTS: Like our previous findings, rutin did not (11.5 or 46 mg/kg, i.v.) reduce the ISO-induced mortality within 2 hours although the lower dose significantly reduced cardiac troponin T (cTnT) and partly improved the histological findings. In contrast, the higher dose increased the mortality in comparison with solvent (1.26% w/v sodium bicarbonate). This was not caused by any specific haemodynamic disturbances. It appears to be associated with oxidative stress as rutin enhanced intracellular reactive oxygen species formation in vitro and had the tendency to increase it in vivo. CONCLUSIONS: Rutin, likely due to its pro-oxidative effects, can exacerbate catecholamine cardiotoxicity depending on the dose used.

b Department of Biochemical Sciences Faculty of Pharmacy in Hradec Králové Charles University Prague Heyrovského 1203 500 05 Czech Republic

c Department of Analytical Chemistry Faculty of Pharmacy in Hradec Králové Charles University Prague Heyrovského 1203 500 05 Czech Republic

Department of Biological and Medical Sciences Faculty of Pharmacy in Hradec Králové Charles University Prague Heyrovského 1203 500 05 Czech Republic

Department of Pharmacology and Toxicology Faculty of Pharmacy in Hradec Králové Charles University Prague Heyrovského 1203 500 05 Czech Republic

e Faculty of Medicine in Hradec Králové Charles University Prague Šimkova 870 500 38 Czech Republic

f University Hospital Hradec Králové Sokolská 581 500 05 Czech Republic

Zobrazit více v PubMed

Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998;56(11):317–33. doi: 10.1111/j.1753-4887.1998.tb01670.x PubMed DOI

Toh JY, Tan VM, Lim PC, Lim ST, Chong MF. Flavonoids from fruit and vegetables: a focus on cardiovascular risk factors. Curr Atheroscler Rep 2013;15(12):368 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24091782. doi: 10.1007/s11883-013-0368-y DOI

Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, et al. . Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007;85(3):895–909. PubMed

Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, et al. . Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008;88(1):38–50. PubMed

Mladenka P, Zatloukalova L, Filipsky T, Hrdina R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic Biol Med 2010;49(6):963–75. doi: 10.1016/j.freeradbiomed.2010.06.010 PubMed DOI

Mladenka P, Macakova K, Filipsky T, Zatloukalova L, Jahodar L, Bovicelli P, et al. . In vitro analysis of iron chelating activity of flavonoids. J Inorg Biochem 2011;105(5):693–701. doi: 10.1016/j.jinorgbio.2011.02.003 PubMed DOI

Seyoum A, Asres K, El-Fiky FK. Structure–radical scavenging activity relationships of flavonoids. Phytochemistry 2006;67(18):2058–70. doi: 10.1016/j.phytochem.2006.07.002 PubMed DOI

Nagao A, Seki M, Kobayashi H. Inhibition of xanthine oxidase by flavonoids. Biosci Biotechnol Biochem 1999;63(10):1787–90. doi: 10.1271/bbb.63.1787 PubMed DOI

Mira L, Fernandez MT, Santos M, Rocha R, Florencio MH, Jennings KR. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 2002;36(11):1199–208. doi: 10.1080/1071576021000016463 PubMed DOI

El Haouari M, Rosado JA. Modulation of platelet function and signaling by flavonoids. Mini Rev Med Chem 2011;11(2):131–42. doi: 10.2174/138955711794519537 PubMed DOI

Riha M, Karlickova J, Filipsky T, Macakova K, Rocha L, Bovicelli P, et al. . In vitro evaluation of copper-chelating properties of flavonoids. RSC Adv 2014;4(62):32628–38. doi: 10.1039/C4RA04575K DOI

Macakova K, Mladenka P, Filipsky T, Riha M, Jahodar L, Trejtnar F, et al. . Iron reduction potentiates hydroxyl radical formation only in flavonols. Food Chem 2012;135(4):2584–92. doi: 10.1016/j.foodchem.2012.06.107 PubMed DOI

Prochazkova D, Bousova I, Wilhelmova N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia 2011;82(4):513–23. doi: 10.1016/j.fitote.2011.01.018 PubMed DOI

Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 1997;22(5):749–60. doi: 10.1016/S0891-5849(96)00351-6 PubMed DOI

Kloner RA. Natural and unnatural triggers of myocardial infarction. Prog Cardiovasc Dis 2006;48(4):285–300. doi: 10.1016/j.pcad.2005.07.001 PubMed DOI

Schömig A. Catecholamines in myocardial ischemia. Systemic and cardiac release. Circulation 1990;82(3 Suppl):II13–22. PubMed

Chagoya de Sánchez V, Hernández-Muñoz R, López-Barrera F, Yañez L, Vidrio S, Suárez J, et al. . Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can J Physiol Pharmacol 1997;75(12):1300–11. doi: 10.1139/y97-154 PubMed DOI

Díaz-Muñoz M, Álvarez-Pérez MA, Yáñez L, Vidrio S, Martínez L, Rosas G, et al. . Correlation between oxidative stress and alteration of intracellular calcium handling in isoproterenol-induced myocardial infarction. Mol Cell Biochem 2006;289(1–2):125–36. doi: 10.1007/s11010-006-9155-1 PubMed DOI

Mladěnka P, Hrdina R, Bobrovová Z, Semecký V, Vávrová J, Holecková M, et al. . Cardiac biomarkers in a model of acute catecholamine cardiotoxicity. Hum Exp Toxicol 2009;28(10):631–40. doi: 10.1177/0960327109350665 PubMed DOI

Berenshtein E, Vaisman B, Goldberg-Langerman C, Kitrossky N, Konijn AM, Chevion M. Roles of ferritin and iron in ischemic preconditioning of the heart. Mol Cell Biochem 2002;234–235(1–2):283–92. doi: 10.1023/A:1015923202082 PubMed DOI

Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17(4):291–306. doi: 10.1016/S0022-2828(85)80130-9 PubMed DOI

Chappel CI, Rona G, Balazs T, Gaudry R. Severe myocardial necrosis produced by isoproterenol in the rat. Arch Int Pharmacodyn Ther 1959;122:123–8. PubMed

Rona G, Chappel CI, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol 1959;67(4):443–55. PubMed

Bindoli A, Rigobello MP, Deeble DJ. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 1992;13(4):391–405. doi: 10.1016/0891-5849(92)90182-G PubMed DOI

Todd GL, Cullan GE, Cullan GM. Isoproterenol-induced myocardial necrosis and membrane permeability alterations in the isolated perfused rabbit heart. Exp Mol Pathol 1980;33(1):43–54. doi: 10.1016/0014-4800(80)90006-4 PubMed DOI

Karthick M, Stanely Mainzen Prince P. Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in rats. J Pharm Pharmacol 2006;58(5):701–7. doi: 10.1211/jpp.58.5.0016 PubMed DOI

Stanely Mainzen Prince P, Karthick M. Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2007;21(1):1–6. doi: 10.1002/jbt.20151 PubMed DOI

Stanely Mainzen Prince P, Priya S. Preventive effects of rutin on lysosomal enzymes in isoproterenol induced cardio toxic rats: biochemical, histological and in vitro evidences. Eur J Pharmacol 2010;649(1–3):229–35. doi: 10.1016/j.ejphar.2010.08.054 PubMed DOI

Punithavathi VR, Shanmugapriya K, Prince PS. Protective effects of rutin on mitochondrial damage in isoproterenol-induced cardiotoxic rats: an in vivo and in vitro study. Cardiovasc Toxicol 2010;10(3):181–9. doi: 10.1007/s12012-010-9077-8 PubMed DOI

Prince PS, Sathya B. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats. Eur J Pharmacol 2010;635(1–3):142–8. doi: 10.1016/j.ejphar.2010.02.019 PubMed DOI

Mladěnka P, Zatloukalová L, Šimůnek T, Bobrovová Z, Semecký V, Nachtigal P, et al. . Direct administration of rutin does not protect against catecholamine cardiotoxicity. Toxicology 2009;255(1–2):25–32. doi: 10.1016/j.tox.2008.09.027 PubMed DOI

Riha M, Voprsalova M, Pilarova V, Semecky V, Holeckova M, Vavrova J, et al. . Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity. Naunyn Schmiedebergs Arch Pharmacol 2014;387(9):823–35. doi: 10.1007/s00210-014-0995-z PubMed DOI

Filipský T, Zatloukalová L, Mladěnka P, Hrdina R. Acute initial haemodynamic changes in a rat isoprenaline model of cardiotoxicity. Hum Exp Toxicol 2012;31(8):830–43. doi: 10.1177/0960327112438927 PubMed DOI

Zatloukalová L, Filipský T, Mladěnka P, Semecký V, Macaková K, Holecková M, et al. . Dexrazoxane provided moderate protection in a catecholamine model of severe cardiotoxicity. Can J Physiol Pharmacol 2012;90(4):473–84. doi: 10.1139/y2012-009 PubMed DOI

Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 2010;99(3):306–14. doi: 10.1016/j.cmpb.2010.01.007 PubMed DOI

Kimes BW, Brandt BL. Properties of a clonal muscle cell line from rat heart. Exp Cell Res 1976;98(2):367–81. doi: 10.1016/0014-4827(76)90447-X PubMed DOI

Šimůnek T, Štěrba M, Popelová O, Kaiserová H, Adamcová M, Hroch M, et al. . Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone. Br J Pharmacol 2008;155(1):138–48. doi: 10.1038/bjp.2008.236 PubMed DOI PMC

Chan EC, Pannangpetch P, Woodman OL. Relaxation to flavones and flavonols in rat isolated thoracic aorta: mechanism of action and structure–activity relationships. J Cardiovasc Pharmacol 2000;35(2):326–33. doi: 10.1097/00005344-200002000-00023 PubMed DOI

Jambhekar SS, Breen PJ. Basic pharmacokinetics. London: Pharmaceutical Press; 2009.

Sharma S, Ali A, Ali J, Sahni JK, Baboota S. Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs 2013;22(8):1063–79. doi: 10.1517/13543784.2013.805744 PubMed DOI

Haenen GRMM, Paquay JBG, Korthouwer REM, Bast A. Peroxynitrite scavenging by flavonoids. Biochem Biophys Res Commun 1997;236(3):591–3. doi: 10.1006/bbrc.1997.7016 PubMed DOI

Moridani MY, Pourahmad J, Bui H, Siraki A, O'Brien PJ. Dietary flavonoid iron complexes as cytoprotective superoxide radical scavengers. Free Radic Biol Med 2003;34(2):243–53. doi: 10.1016/S0891-5849(02)01241-8 PubMed DOI

Firuzi O, Mladênka Pe, Petrucci R, Marrosu G, Saso L. Hypochlorite scavenging activity of flavonoids. J Pharm Pharmacol 2004;56(6):801–7. doi: 10.1211/0022357023556 PubMed DOI

Guardia T, Rotelli AE, Juarez AO, Pelzer LE. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 2001;56(9):683–7. doi: 10.1016/S0014-827X(01)01111-9 PubMed DOI

Ugusman A, Zakaria Z, Chua KH, Megat Mohd Nordin NA, Abdullah Mahdy Z. Role of rutin on nitric oxide synthesis in human umbilical vein endothelial cells. ScientificWorldJournal 2014;2014:169370 Available from: http://www.hindawi.com/journals/tswj/2014/169370/ doi: 10.1155/2014/169370 PubMed DOI PMC

Sheu J-R, Hsiao G, Chou P-H, Shen M-Y, Chou D-S. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J Agric Food Chem 2004;52(14):4414–8. doi: 10.1021/jf040059f PubMed DOI

Labuda J, Bučková M, Heilerová Ľ, Šilhár S, Štepánek I. Evaluation of the redox properties and anti/pro-oxidant effects of selected flavonoids by means of a DNA-based electrochemical biosensor. Anal Bioanal Chem 2003;376(2):168–73. PubMed

Manach C, Morand C, Texier O, Favier ML, Agullo G, Demigne C, et al. . Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 1995;125(7):1911–22. PubMed

Erlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J, et al. . Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 2000;56(8):545–53. doi: 10.1007/s002280000197 PubMed DOI

Rechner AR, Smith MA, Kuhnle G, Gibson GR, Debnam ES, Srai SK, et al. . Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic Biol Med 2004;36(2):212–25. doi: 10.1016/j.freeradbiomed.2003.09.022 PubMed DOI

Serra A, Macià A, Romero M-P, Reguant J, Ortega N, Motilva M-J. Metabolic pathways of the colonic metabolism of flavonoids (flavonols, flavones and flavanones) and phenolic acids. Food Chem 2012;130(2):383–93. doi: 10.1016/j.foodchem.2011.07.055 DOI

Choudhury R, Srai SK, Debnam E, Rice-Evans CA. Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. Free Radic Biol Med 1999;27(3–4):278–86. doi: 10.1016/S0891-5849(99)00054-4 PubMed DOI

Tang D, Yin Y, Zhang Z, Gao Y, Wei Y, Chen Y, et al. . Simultaneous HPLC-DAD analysis of five flavonoids in diabetic rat plasma and its application in the study of pharmacokinetics. Acta Chromatographica 2009;21(3):483–97. doi: 10.1556/AChrom.21.2009.3.11 DOI

Wang SY, Chai JY, Zhang WJ, Liu X, Du Y, Cheng ZZ, et al. . HPLC determination of five polyphenols in rat plasma after intravenous administration of hawthorn leaves extract and its application to pharmacokinetic study. Yakugaku Zasshi 2010;130(11):1603–13. doi: 10.1248/yakushi.130.1603 PubMed DOI

Yang CY, Hsiu SL, Wen KC, Lin SP, Tsai SY, Hou YC, et al. . Bioavailability and metabolic pharmacokinetics of rutin and quercetin in rats. J Food Drug Anal 2004;13(3):244–50.

Mladenka P, Hrdina R, Filipsky T, Riha M, Palicka V. Is a highly linear relationship between the dose of quercetin and the pharmacological effect possible? – a comment on Liu, et al. Evaluation of antioxidant and immunity activities of quercetin in isoproterenol-treated rats. Molecules 2012;17:4281–4291. Molecules 2014;19(7):9606–9. doi: 10.3390/molecules19079606 PubMed DOI PMC

Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C. Bioavailability of rutin and quercetin in rats. FEBS Lett 1997;409(1):12–6. doi: 10.1016/S0014-5793(97)00467-5 PubMed DOI

Ambrosio G, Zweier JL, Jacobus WE, Weisfeldt ML, Flaherty JT. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 1987;76(4):906–15. doi: 10.1161/01.CIR.76.4.906 PubMed DOI

Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Martinez JA. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 2009;58(9):537–52. doi: 10.1007/s00011-009-0037-3 PubMed DOI

Strobel NA, Fassett RG, Marsh SA, Coombes JS. Oxidative stress biomarkers as predictors of cardiovascular disease. Int J Cardiol 2011;147(2):191–201. doi: 10.1016/j.ijcard.2010.08.008 PubMed DOI

Mladenka P, Zatloukalova L, Filipsky T, Vavrova J, Holeckova M, Palicka V, et al. . Common biomarkers of oxidative stress do not reflect cardiovascular dys/function in rats. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013;157(2):146–52. PubMed

Haskova P, Kovarikova P, Koubkova L, Vavrova A, Mackova E, Simunek T. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity. Free Radic Biol Med 2011;50(4):537–49. doi: 10.1016/j.freeradbiomed.2010.12.004 PubMed DOI

Mladenka P, Kalinowski DS, Haskova P, Bobrovova Z, Hrdina R, Simunek T, et al. . The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity. Chem Res Toxicol 2009;22(1):208–17. doi: 10.1021/tx800331j PubMed DOI

Costa VM, Silva R, Ferreira LM, Branco PS, Carvalho F, Bastos ML, et al. . Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: formation of adrenochrome, quinoproteins, and GSH adduct. Chem Res Toxicol 2007;20(8):1183–91. doi: 10.1021/tx7000916 PubMed DOI

Costa VM, Silva R, Ferreira R, Amado F, Carvalho F, de Lourdes Bastos M, et al. . Adrenaline in pro-oxidant conditions elicits intracellular survival pathways in isolated rat cardiomyocytes. Toxicology 2009;257(1–2):70–9. doi: 10.1016/j.tox.2008.12.010 PubMed DOI

Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005;10(Suppl 1):S10–23. doi: 10.1080/13547500500216546 PubMed DOI